Welcome to the investors section of Adocia  

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.


Latest Press Releases
2017/04/18Adocia announces the release of its Reference Document, containing the Annual Financial Report and the Management Report, for the year 2016
Read more
2017/04/18Adocia announces first quarter 2017 financial results
Read more

All Press releases

Next events

30 mai 2017 15th Healthcare Midcaps Forum – Gilbert Dupont Bank brokerage firm – Paris, France - Some thirty Midcaps, representative of the health sector, will meet with a large population of Institutional and Private Managers of the strategy and prospects of their company
See event

All events